Phase I Combination w/ Epirubicin

NCT00322374 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Ixabepilone
DRUG: Epirubicin

Sponsor

R-Pharm